Galectin Therapeutics
GALT
#8225
Rank
โ‚น13.76 B
Marketcap
โ‚น220.97
Share price
1.15%
Change (1 day)
26.95%
Change (1 year)

Galectin Therapeutics (GALT) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น9.22 Billion

According to Galectin Therapeutics's latest financial reports the company's total liabilities are โ‚น9.22 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galectin Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚น4.42 B51.63%
2021-12-31โ‚น2.91 B638.05%
2020-12-31โ‚น0.39 B93.08%
2019-12-31โ‚น0.20 B38.95%
2018-12-31โ‚น0.14 B-22.22%
2017-12-31โ‚น0.18 B-26.22%
2016-12-31โ‚น0.25 B184.21%
2015-12-31โ‚น90.37 M-16.26%
2014-12-31โ‚น0.10 B-29.72%
2013-12-31โ‚น0.15 B70.62%
2012-12-31โ‚น90.01 M-23.18%
2011-12-31โ‚น0.11 B-67.29%
2010-12-31โ‚น0.35 B57.46%
2009-12-31โ‚น0.22 B303.51%
2008-12-31โ‚น56.38 M-69.47%
2007-12-31โ‚น0.18 B-34.69%
2006-12-31โ‚น0.28 B355.38%
2005-12-31โ‚น62.1 M42.68%
2004-12-31โ‚น43.52 M152.9%
2003-12-31โ‚น17.21 M-46.18%
2002-12-31โ‚น31.97 M20.34%
2001-12-31โ‚น26.57 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น15.39 B 66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น56.25 B 509.84%๐Ÿ‡บ๐Ÿ‡ธ USA